Research ArticleMethodology
Time-Dose-Fractionation in Radioimmunotherapy: Implications for Selecting Radionuclides
Dandamudi V. Rao and Roger W. Howell
Journal of Nuclear Medicine October 1993, 34 (10) 1801-1810;


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Time-Dose-Fractionation in Radioimmunotherapy: Implications for Selecting Radionuclides
Dandamudi V. Rao, Roger W. Howell
Journal of Nuclear Medicine Oct 1993, 34 (10) 1801-1810;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Harnessing the Energy: Development of Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma
- MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry--Standardization of Nomenclature
- MIRD Commentary: Proposed Name for a Dosimetry Unit Applicable to Deterministic Biological Effects--The Barendsen (Bd)
- Three-Dimensional Radiobiologic Dosimetry: Application of Radiobiologic Modeling to Patient-Specific 3-Dimensional Imaging-Based Internal Dosimetry
- Dosimetry-Guided Radioactive Iodine Treatment in Patients with Metastatic Differentiated Thyroid Cancer: Largest Safe Dose Using a Risk-Adapted Approach
- Biologic Dosimetry of Bone Marrow: Induction of Micronuclei in Reticulocytes After Exposure to 32P and 90Y
- Radioimmunotherapy of Human Colon Cancer Xenografts Using a Dimeric Single-Chain Fv Antibody Construct